• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,415.35 231.99
( 0.31%)
Global Indices
Nasdaq
50,600.73 294.06
(0.58%)
Dow Jones
7,493.73 27.01
(0.36%)
Hang Seng
63,328.42 1,644.28
(2.67%)
Nikkei 225
10,474.02 30.55
(0.29%)
Forex
USD-INR
96.29 -0.42
(-0.43%)
EUR-INR
111.82 -0.44
(-0.39%)
GBP-INR
129.28 -0.40
(-0.31%)
JPY-INR
0.61 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
99.2482659
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
101.44
442725.29
EPS(TTM)
Face Value()
Div & Yield %
18.19
1
0.87
 

Amber Enterprises India consolidated net profit rises 15.34% in the March 2026 quarter
May 16,2026
Net profit of Amber Enterprises India rose 15.34% to Rs 133.88 crore in the quarter ended March 2026 as against Rs 116.07 crore during the previous quarter ended March 2025. Sales rose 10.49% to Rs 4147.52 crore in the quarter ended March 2026 as against Rs 3753.70 crore during the previous quarter ended March 2025.

For the full year,net profit declined 27.06% to Rs 177.65 crore in the year ended March 2026 as against Rs 243.56 crore during the previous year ended March 2025. Sales rose 22.19% to Rs 12186.48 crore in the year ended March 2026 as against Rs 9973.02 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales4147.523753.70 10 12186.489973.02 22
OPM %7.027.51 -7.087.35 -
PBDT246.58246.56 0 698.04598.27 17
PBT147.29188.59 -22 375.49369.96 1
NP133.88116.07 15 177.65243.56 -27